Reliability, Satisfaction and Effectiveness of Benralizumab Home Self-Administration in Patients with Severe Eosinophilic Asthma in Real-World Practice: The Auto-Benra Study

Ismael García-Moguel,1,2 Ana Rosado,3 Aída Gómez-Cardeñosa,4,5 Mar Gandolfo-Cano,6,7 Teresa Robledo Echarren,8 Maria del Mar Moro Moro,9 Mª del Mar Reaño Martos,10 Rafael Pineda-Pineda,11 Marcela Valverde-Monge,4,5 Cristina Martin-Arriscado Arroba,12 Javier Domínguez-Ortega13 On behalf of the AIRE G...

書誌詳細
出版年:	Journal of Asthma and Allergy
主要な著者:	García-Moguel I, Rosado A, Gómez-Cardeñosa A, Gandolfo-Cano M, Robledo Echarren T, Moro Moro MDM, Reaño Martos MDM, Pineda-Pineda R, Valverde-Monge M, Martin-Arriscado Arroba C, Domínguez-Ortega J
フォーマット:	論文
言語:	英語
出版事項:	Dove Medical Press 2022-05-01
主題:	benralizumab severe eosinophilic asthma self-administration severe asthma eosinophilic asthma.
オンライン･アクセス:	https://www.dovepress.com/reliability-satisfaction-and-effectiveness-of-benralizumab-home-self-a-peer-reviewed-fulltext-article-JAA

類似資料

Real-life experience with benralizumab during 6 months
著者:: A. Padilla-Galo, 等
出版事項: (2020-06-01)

Clinical profile of comorbidities in patients with severe asthma undergoing benralizumab biologic therapy
著者:: Mărginean Corina, 等
出版事項: (2026-03-01)

Switching from one biologic to benralizumab in patients with severe eosinophilic asthma: An ANANKE study post hoc analysis
著者:: Cristiano Caruso, 等
出版事項: (2022-09-01)

Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy
著者:: Corrado Pelaia, 等
出版事項: (2021-12-01)

Successful discontinuation of corticosteroids through remission induction therapy with benralizumab for chronic eosinophilic pneumonia
著者:: Yoshiro Kai, 等
出版事項: (2024-01-01)

Efficacy of Benralizumab in Reducing FeNO in Severe Eosinophilic Asthma: The Role of CRSwNP
著者:: Garcia-Rivero JL, 等
出版事項: (2025-05-01)

Benralizumab and the integrated management of co‐morbid severe eosinophilic asthma with chronic rhinosinusitis with nasal polyps
著者:: Joaquim Mullol, 等
出版事項: (2025-04-01)

Safety and effectiveness of benralizumab in Indian patients with severe eosinophilic asthma: results from the FAST study
著者:: Deepak Talwar, 等
出版事項: (2026-04-01)

Benralizumab treatment and 3-dimensional bronchial tree changes in chronic eosinophilic pneumonia
著者:: Yoshiro Kai, MD, PhD, 等
出版事項: (2025-08-01)

Rapid Effect of Benralizumab for Hypereosinophilia in a Case of Severe Asthma with Eosinophilic Chronic Rhinosinusitis
著者:: Hiroaki Tsurumaki, 等
出版事項: (2019-07-01)

The Comparative Effectiveness of Mepolizumab and Benralizumab in the Treatment of Eosinophilic Asthma
著者:: Aleksandra Niemiec-Górska, 等
出版事項: (2025-06-01)

Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma
著者:: Drick N, 等
出版事項: (2020-11-01)

Pharmacoeconomic analysis of using benralizumab for treatment of severe asthma in inpatient and outpatient settings
著者:: M. V. Zhuravleva, 等
出版事項: (2022-07-01)

Autoimmune hepatitis with eosinophilic infiltration responsive to anti-interleukin-5 receptor treatment: a case report and literature review
著者:: Francesca Romana Ponziani, 等
出版事項: (2023-10-01)

Clinical and economic comparison of utilization of reslizumab, mepolizumab and benralizumab in the treatment of severe eosinophilic asthma
著者:: S. K. Zyryanov, 等
出版事項: (2020-12-01)

Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study
著者:: Alessandra Vultaggio, 等
出版事項: (2023-05-01)

Safety and efficacy of monoclonal antibodies targeting IL-5 in severe eosinophilic asthma: A systematic review and meta-analysis of randomized controlled trials
著者:: Noor Alam, 等
出版事項: (2023-09-01)

Sustained Effectiveness of Benralizumab in Naïve and Biologics-Experienced Severe Eosinophilic Asthma Patients: Results from the ANANKE Study
著者:: Cameli P, 等
出版事項: (2024-03-01)

New therapy options for patients with eosinophilic type of severe bronchial asthma
著者:: G. L. Ignatova, 等
出版事項: (2020-01-01)

Clinical Features and Efficacy of Benralizumab in Patients with Blood Eosinophil Count Between 300 and 450 Cells/mm3: A Post Hoc Analysis from the ANANKE Study
著者:: Senna G, 等
出版事項: (2022-11-01)

Experience with mepolizumab in adults with severe eosinophilic asthma: a case series from India
著者:: Venkata Nagarjuna Maturu, 等
出版事項: (2021-08-01)

Durability of benralizumab effectiveness in severe eosinophilic asthma patients with and without chronic rhinosinusitis with nasal polyps: a post hoc analysis from the ANANKE study
著者:: Luisa Brussino, 等
出版事項: (2025-03-01)

Patient-Reported Outcomes with Benralizumab in Patients with Severe Eosinophilic Asthma and Severe Chronic Rhinosinusitis with Nasal Polyps
著者:: Rory Chan, 等
出版事項: (2023-03-01)

Benralizumab: Effectiveness in Patients with Uncontrolled Severe Eosinophilic Asthma at 6 and 12 Months at a Third-Level Care Hospital. Capacity for ICS-LABA Therapy Reduction
著者:: González-Tuyub YH, 等
出版事項: (2024-11-01)

Modulation of blood inflammatory markers by benralizumab in patients with eosinophilic airway diseases
著者:: Sriram Sridhar, 等
出版事項: (2019-01-01)

Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: ORBE II study
著者:: Alicia Padilla-Galo, 等
出版事項: (2023-09-01)

Out of Breath, out of Options: Benralizumab as a Last Hope in ICU‐Treated Near‐Fatal Eosinophilic Asthma: A Case Series
著者:: Lennart Conemans, 等
出版事項: (2025-03-01)

Severe Asthma or Chronic Obstructive Pulmonary Disease with Eosinophilic Inflammation? From Uncertainty to Remission under Anti IL-5R Therapy
著者:: Bianca Oprescu, 等
出版事項: (2024-02-01)

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
著者:: Steven W. Yancey, 等
出版事項: (2019-09-01)

Real word effectiveness of benralizumab in mexican patients with severe eosinophilic asthma: Responders and super-responders
著者:: Ulises Noel García Ramírez, 等
出版事項: (2026-03-01)

Early and Sustained Response to Benralizumab in Severe, Eosinophilic Asthma: A Real-World Observational Study
著者:: Stolz D, 等
出版事項: (2024-12-01)

Very long-term data on patients with severe eosinophilic asthma treated with mepolizumab: a case series
著者:: Carlo Lombardi, 等
出版事項: (2024-07-01)

Successful Introduction of Benralizumab for Eosinophilic Ascites
著者:: Nabil Belfeki, 等
出版事項: (2024-01-01)

Severe eosinophilic bronchial asthma: new therapeutic options
著者:: N. M. Nenasheva
出版事項: (2018-10-01)

Evaluation of the Effectiveness of Benralizumab in a Patient with Severe Bronchial Asthma
著者:: Anna A. Dyachkova, 等
出版事項: (2025-01-01)

B cell activating factor (BAFF) levels are associated with failed remission after 12 months of treatment with benralizumab and mepolizumab in severe asthma
著者:: Bettina Corinna Fischer, 等
出版事項: (2026-04-01)

Successful benralizumab therapy for severe asthma secondary to EGPA refractory to mepolizumab
著者:: Andrea Ofelia García Vaca, 等
出版事項: (2025-09-01)

Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA)
著者:: Panettieri RA Jr, 等
出版事項: (2020-02-01)

Real-World Safety and Effectiveness of Benralizumab in Japanese Patients with Severe Asthma: A Multicenter Prospective Observational Study
著者:: Yamaguchi M, 等
出版事項: (2024-01-01)

Daily patient-reported health status assessment improvements with benralizumab for patients with severe, uncontrolled eosinophilic asthma
著者:: O'Quinn S, 等
出版事項: (2019-01-01)